Kamada Ltd. (TLV:KMDA)
2,673.00
-14.00 (-0.52%)
At close: Mar 19, 2026
Kamada Market Cap
Kamada has a market cap or net worth of 1.54 billion as of March 19, 2026. Its market cap has increased by 0.11% in one year.
Market Cap
1.54B
Enterprise Value
1.34B
Revenue
575.31M
Ranking
n/a
PE Ratio
23.96
Stock Price
2,673.00
Market Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.54B, an increase of 1,728.02%. That is a compound annual growth rate of 15.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 1.55B | 18.90% |
| Dec 31, 2025 | 1.30B | 2.55% |
| Dec 31, 2024 | 1.27B | -0.69% |
| Dec 31, 2023 | 1.28B | 108.12% |
| Dec 29, 2022 | 615.02M | -33.18% |
| Dec 30, 2021 | 920.36M | -0.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 107.28B |
| Danel (Adir Yeoshua) | 2.62B |
| BrainsWay | 1.70B |
| SofWave Medical | 1.36B |
| Bait Bakfar | 980.47M |
| Ilex Medical | 670.50M |
| Novolog (Pharm-Up 1966) | 592.10M |
| Bonus BioGroup | 469.51M |